Does Rallies show 13F holders for NAUT?

Yes. Rallies tracks hedge fund and 13F ownership data for NAUT, including fund names, share counts, latest tracked quarter, and position changes when available.

Is NAUT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for NAUT. It does not provide personalized investment advice.

NAUT (Nautilus Biotechnolgy, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Nautilus Biotechnolgy, Inc. Common Stock (NAUT) is a publicly traded Healthcare sector company. As of May 21, 2026, NAUT trades at $2.38 with a market cap of $299.91M and a P/E ratio of -5.01. NAUT moved +0.00% today. Year to date, NAUT is +25.93%; over the trailing twelve months it is +189.54%. Its 52-week range spans $0.62 to $4.31. Analyst consensus is buy with an average price target of $4.00. Rallies surfaces NAUT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns NAUT stock?

Hedge funds tracked by Rallies that own NAUT include Polen Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Nautilus Biotechnolgy, Inc. Common Stock.

NAUT Key Metrics

Key financial metrics for NAUT
Metric	Value
Price	$2.38
Market Cap	$299.91M
P/E Ratio	-5.01
EPS	$-0.47
Dividend Yield	0.00%
52-Week High	$4.31
52-Week Low	$0.62
Volume	313.01K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-59.00M
Gross Margin	0.00%

Top Hedge Funds Holding NAUT

Polen Capital holds 40.34K shares of NAUT, changed +0.00% as of Mar 31, 2026.

Latest NAUT News

Nautilus Launches Tau Early Access Program, Cuts Q1 Expenses 14% — Apr 28, 2026
Nautilus Biotechnology Appoints Sales VP to Lead Late-2026 Voyager Platform Launch — Mar 2, 2026
Nautilus Unveils Voyager Instrument, Launches Early Access Program with Cash Runway to 2027 — Feb 26, 2026
Nautilus Biotechnology Cuts Q4 Expenses 23% to $15.4M, Prepares Voyager Launch — Feb 26, 2026
Nautilus Launches Voyager Platform Mapping 10 Billion Proteins, Early 2026 Access Program — Feb 24, 2026

Recent NAUT Insider Trades

Patel Sujal M bought 25.00K (~$65.24K) on Mar 4, 2026.
Suzuki Kentaro bought 4.00K (~$5.96K) on Nov 6, 2025.
Patel Sujal M bought 83.50K (~$57.03K) on Sep 8, 2025.

NAUT Analyst Consensus

2 analysts cover NAUT: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.00.

Common questions about NAUT

Who owns NAUT stock?: Hedge funds tracked by Rallies that own NAUT include Polen Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Nautilus Biotechnolgy, Inc. Common Stock.
Does Rallies show 13F holders for NAUT?: Yes. Rallies tracks hedge fund and 13F ownership data for NAUT, including fund names, share counts, latest tracked quarter, and position changes when available.
Is NAUT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for NAUT. It does not provide personalized investment advice.